Fundraising

Cairn Therapeutics is raising a Series A round to support our First in Human Phase I trial, which is scheduled to begin in Q4’25. We have completed all necessary preclinical studies and are finalizing our Drug Product, set for completion by Q3’25. With our IND submission planned for the end of Q3’25, your investment will be pivotal in advancing our groundbreaking cancer therapies.